2002
DOI: 10.1016/s1074-3804(05)60517-8
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Adhesions with Crystalloids during Laparoscopic Surgery in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 29 publications
(21 citation statements)
references
References 15 publications
0
21
0
Order By: Relevance
“…However, Elkelani et al [14] confirmed that adhesiogenesis mechanisms were different after laparoscopy and laparotomy. For that purpose, CO 2 pneumoperitoneum appears like a cofactor in adhesion formation [9,15].…”
Section: Discussionmentioning
confidence: 99%
“…However, Elkelani et al [14] confirmed that adhesiogenesis mechanisms were different after laparoscopy and laparotomy. For that purpose, CO 2 pneumoperitoneum appears like a cofactor in adhesion formation [9,15].…”
Section: Discussionmentioning
confidence: 99%
“…The experimental setup (i.e., animals, anesthesia, ventilation, laparoscopic surgery, and induction and adhesion scoring) has been described in detail elsewhere (4,5,(21)(22)(23)(24)(25). The model consisted of a bipolar lesion made at the begining of a 60 minutes pneumoperitoneum during laparoscopy.…”
Section: Materials and Methods Laparoscopic Mouse Model For Adhesion mentioning
confidence: 99%
“…The experimental setup (i.e., animals, anesthesia and ventilation, laparoscopic surgery, and induction and scoring of intraperitoneal adhesions) has been described in detail previously [49,[71][72][73][74][75][76][77]. Briefly, the model consisted of pneumoperitoneum-enhanced adhesions induced during laparoscopy by creation of a mechanical lesion.…”
Section: The Laparoscopic Mouse Model For Adhesion Formationmentioning
confidence: 99%
“…Some products have been demonstrated to decrease postoperative adhesions during laparoscopy including antibodies against vascular endothelial growth factor receptor 1 (VEGF-R1) [48], crystalloids [49,50], 4% icodextrin [50], ferric hyaluronate gel [50][51][52], Sepracoat [53], a crosslinked hyaluronan solution [54], and hyaluronate membrane [55].…”
mentioning
confidence: 99%